Weston et al. are currently investigating the effects of siRNA-EPHA2 in tumor metabolism and perfusion, utilizing diffusion weighted MRI and 18FDG-PET [72], while Huang et al. explored the efficacy of EPHA2-specific taxane-loaded immunoliposomes [71]. Here, EPHA2 is linked to neoplasm.